Anne Sheu
Caliway Biopharmaceuticals Co., Ltd.
12
0
7
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (12)
Showing 10 of 12 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Murad Alam, MD
Northwestern University
Shared therapeutic areas:
David Goldberg, MD
Skin Laser & Surgery Specialist of NY/NJ
Shared therapeutic areas:
Girish Munavalli, MD
Laser & Vein Specialists of the Carolinas, 1918 Randolph Road, Suite 550, Charlotte, NC 28270
Shared therapeutic areas:
Doris Hexsel, MD
Hexsel Dermatology Clinic
Shared therapeutic areas:
Axel Franz
University Hospital Tuebingen
Shared therapeutic areas:
Macrene Alexiades, MD
Dermatology and Laser Surgery Center 955 Park Avenue, New York, NY, 10028
Shared therapeutic areas:
Leyda R Bowes, MD
Riverchase Dermatology
Shared therapeutic areas:
Karen Chajko
Endo USA Inc., a Keenova Therapeutics Company
Shared therapeutic areas:
David Hernandez
Endo USA Inc., a Keenova Therapeutics Company
Shared therapeutic areas:
Scott Kramer, MD
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (12)
Showing 12 of 12 trials
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1)
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)
A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)
All 12 trials loaded